Barcelona Conferences on Epigenetics and Cancer

21st and 22nd November 2013

CosmoCaixa. C/ Isaac Newton, 26. Barcelona, Spain

Scientific leaders

Manuel Perucho
Director of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC)

Marcus Buschbeck
Investigator of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC)

Poster

cancerepigenics_poster_0.pdf

Program

bdebate_imppc_epigeneticscancer_program_141113_0.pdf

Dossier

bdebate_imppc_dossier_141113_web_low.pdf

Tabs

Description

One of the biggest challenges in biomedicine today is understanding how signal pathways regulated by the interaction of genetic programming and environmental factors impact on the epigenetic plasticity of chromatin in health and disease. This knowledge could be exploited for the generation and improvement of novel tools for the prediction, the diagnosis, and eventually the individualized treatment of cancer.

As a joint venture of five leading Barcelonian institutes, the Barcelona Conferences of Epigenetics and Cancer (BCEC) series has been launched to bring together leading investigators in the fields of chromatin research and cancer. We will discuss fundamental aspects of cancer biology and epigenetics and the possibilities to exploit this knowledge for the development of novel tools for the management of cancer.

The first of the BCEC series, is coorganized by B·Debate and IMPPC, and will focus on discussing in breadth and depth the current challenges, opportunities and perspectives of cancer epigenetics. More specialized topics will ensue in subsequent years.

Abstracts of the Speakers
Press

Short talks will be selected from abstracts. Deadline for abstracts, 6 September at 12.00h Short talk speakers will be contacted at the end of September.

Agenda

Thursday, November 21, 2013
SESSION 1: MOLECULAR EPIGENETICS	Chair: Miguel Beato
Title to be determined	Thomas Jenuwein	Max-Planck-Institute of Immunology and Epigenetics. Germany
Title to be determined	Kristian Helin	Biotech research and Innovation Centre. Denmark
Title to be determined	Sandra Peiró	Hospital del Mar Medical Research Institute (IMIM), Spain
Title to be determined	Short Talk 2	To be selected from submitted abstracts
SESSION 2: EPIGENETIC MECHANISMS OF DIFFERENTIATION AND DEVELOPMENT	Chair: Albert Jordan
Title to be determined	Raffaella Santoro	University of Zurich, Switzerland
MacroH2A – an epigenetic regulator of cancer and differentiation	Marcus Buschbeck	Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Spain
Title to be determined	Short Talk 3	To be selected from submitted abstracts
Title to be determined	Short Talk 4	To be selected from submitted abstracts
SESSION 3: ABERRANT PATTERN OF CHROMATIN MODIFICATIONS IN CANCER	Chair: Eduard Batlle
Title to be determined	Andrew Feinberg	Johns Hopkins University, USA
Title to be determined	Manuel Perucho	Institute of Personalized and Predictive Medicine of Cancer (IMPPC), Spain
Title to be determined	Short Talk 5	To be selected from submitted abstracts
Title to be determined	Short Talk 6	To be selected from submitted abstracts
SESSION 4:STEMS CELLS ND CANCER	Chair: Manuel Perucho
Title to be determined	Luciano di Croce	Center for Genomic Regulation (CRG), Barcelona, Spain
Title to be determined	Short Talk 7	To be selected from submitted abstracts
Title to be determined	EMBO Keynote Lecture, Rudolf Jaenisch	Whitehead Institute, MIT, USA
Poster Session and Networking

Friday, 22 November, 2013
SESSION 5: EPIGENETICS	Chair: Marcus Buschbeck
Title to be determined	Bing Ren	University of California, San Diego, USA
Title to be determined	Short Talk 8	To be selected from submitted abstracts
Title to be determined	Henk Stunnenberg	Radboud University, Netherlands
SESSION 6: EPIGENETIC MECHANISMS AS POINT OF THERAPEUTIC INTERVENTION	Chair: Manel Esteller
Title to be determined	Tony Kouzarides	Gurdon Institute Cambridge, UK
Title to be determined	Manel Esteller	Epigenetic and Cancer Program (PEBC-IDIBELL), Barcelona Spain
Title to be determined	Short Talk 9	To be selected from submitted abstracts
Title to be determined	Josep Carreras Leukaemia Research Institute Lecture, Carlo M. Croce	Ohio State University, USA
Closing Remarks